Skip to main content
. 2020 Dec 4;9(12):3939. doi: 10.3390/jcm9123939

Table 1.

Overview of the differentially expressed miRNAs analyzed in muscle biopsies.

Study miRNAs Muscle Biopsy Sample Size Normalization Targets Associated Pathological Signs and Mechanisms
Gambardella 2010 [48] miR-206 Vastus lateralis 7 DM1
4 ctrls
Hsa-let-7a
Perbellini 2011 [51] miR-1 *
miR-29b/c **
miR-335
miR-33



Biceps branchi 15 DM1
14 ctrls
miR-16 MEF2a *,1
MET *,1
GATA6 *,1
HAND2 *,1
muscle development 1
KCNE1 *,2
KCNJ2 *,2
CALM2 *,2
Arrhythmia 2
SFRS9 *,3 Splicing 3
DAG1 **,4
DIABLO **,4
RET **TRIM63 **,4
TGFB3 **,4
Atrophy 4
Fernandez-Costa 2012 [52] miR-1 ***
miR-7 ****
miR-10 *****


Vastus lateralis
Biceps branchi
Deltoid
5 DM1
3 ctrls
Sno-RNA RNU48 SOD1 ***,5
SMARCA4 ***,6
NET 1 ***,7
CTSB ****,8
ATG4 ****,9
VCL ****,10
UBE11 *****,11
Free radical removal 5
Transcription 6
Apoptosis and signal transduction 7
Proteolysis 8
Autophagy 9
Cytoskeleton 10
Protein localization/activity regulation 11
Fritegotto 2017 [53] miR-1
miR-133a/b
miR206


Vastus lateralis 12 DM1
6 ctrls
Hsa-let-7a
Ambrose 2017 [52] miR-1
miR-133a
miR-29c


Biceps branchi
Gastrocnemius
Deltoid
9 DM1
9 ctrls
Hsa-let-7a

↑ = upregulation, ↓ = downregulation, DM1 = DM1 patients, ctrls = healthy subjects, colors indicate to which miRNA the targets belong. Normalization stands for the miRNA, either endogenous or spike-in, that has been used to normalize the differentially expressed miRNAs. *, **, ***, ****, *****, indicate to which miRNA the targets belong. 1–11 numbers indicates which Associated Pathological Signs and Mechanisms belong to which target.